ENSG00000263001 Expression In 33 Tumors
Ensembl ID |
Gene symbol |
Log2 Foldchange |
Pvaue |
Cancer |
ENSG00000263001 |
|
-0.6 |
4.06e-12 |
KIRC |
Ensembl ID |
Gene symbol |
Cancer types |
Pubmed ID |
ENSG00000263001 |
|
pancreatic cancer |
15760841 |
ENSG00000263001 |
|
breast cancer |
16611241 |
ENSG00000263001 |
|
prostate cancer |
19097122 |
ENSG00000263001 |
|
breast cancer |
21407215 |
ENSG00000263001 |
|
prostate cancer |
21503958 |
ENSG00000263001 |
|
tumour |
24231951 |
ENSG00000263001 |
|
thymic epithelial tumors |
24974848 |
ENSG00000263001 |
|
tumors |
25676695 |
ENSG00000263001 |
|
Liver Cancer |
25869096 |
ENSG00000263001 |
|
tumor |
26656605 |
ENSG00000263001 |
|
tumors |
28400429 |
ENSG00000263001 |
|
cancer |
28427205 |
ENSG00000263001 |
|
tumor |
28448514 |
ENSG00000263001 |
|
thymic epithelial tumors |
28676218 |
ENSG00000263001 |
|
Thymic Epithelial Tumors |
28982856 |
ENSG00000263001 |
|
tumors |
30897085 |
ENSG00000263001 |
|
breast cancer |
31215771 |
ENSG00000263001 |
|
breast cancer |
31874549 |
Ensembl ID |
Gene symbol |
Disease/phenotype |
Mutation type |
Mutated / Total samples |
Literature |
Ensembl ID |
Gene symbol |
Cancer |
P-value |
Which worse |
show |
ENSG00000263001 |
|
SARC |
0.018 |
high |
|
ENSG00000263001 |
|
STAD |
0.0024 |
low |
|
ENSG00000263001 |
|
CHOL |
0.032 |
low |
|
ENSG00000263001 |
|
UVM |
0.0085 |
low |
|
ENSG00000263001 |
|
PAAD |
0.011 |
high |
|
ENSG00000263001 |
|
UCEC |
0.014 |
high |
|
ENSG00000263001 |
|
LGG |
0.0054 |
high |
|
ENSG00000263001 |
|
LUSC |
0.013 |
low |
|
ENSG00000263001 |
|
KIRP |
0.027 |
high |
|
ENSG00000263001 |
|
ESCA |
0.00019 |
low |
|
ENSG00000263001 |
|
BLCA |
0.028 |
high |
|
ENSG00000263001 |
|
CESC |
0.015 |
high |
|
Ensembl ID |
Gene symbol |
Cancer |
CNV type |
-log10(q-value) |
G-score |
average amplitude |
frequency |
ENSG00000263001 |
|
GBM |
Amp |
0.691991 |
0.066593 |
0.779676 |
0.824957 |
ENSG00000263001 |
|
TGCT |
Amp |
1.244648 |
0.142598 |
0.541014 |
0.793333 |